Medtronic plc, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.
Company profile
Ticker
MDT
Exchange
Website
CEO
Geoffrey Martha
Employees
Location
Fiscal year end
Industry (SIC)
Varian Medical Systems • Conmed • Integer • Masimo • Natus Medical • LivaNova • GigCapital5 • Outset Medical • Fonar • Cutera ...
Former names
Medtronic Holdings Ltd, Medtronic Ltd
SEC CIK
Corporate docs
Subsidiaries
2074417 Alberta ULC • A&E Products de Honduras S.A. • A&E Products do Brasil Ltda. • A&E Products Group, Inc. • Advanced Medical Technologies GmbH • AI Biomed Corp • Aircraft Medical Ltd. • Airox, Inc. • Arterial Vascular Engineering Canada, Company • Arterial Vascular Engineering UK Limited ...
MDT stock data
Analyst ratings and price targets
Latest filings (excl ownership)
424B5
Prospectus supplement for primary offering
24 Mar 23
FWP
Free writing prospectus
23 Mar 23
424B3
Prospectus supplement
23 Mar 23
25-NSE
Exchange delisting
15 Mar 23
25-NSE
Exchange delisting
10 Mar 23
8-K
Regulation FD Disclosure
9 Mar 23
8-K
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
7 Mar 23
S-3ASR
Automatic shelf registration
3 Mar 23
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
1 Mar 23
10-Q
2023 Q3
Quarterly report
1 Mar 23
Transcripts
MDT
Earnings call transcript
2023 Q3
21 Feb 23
MDT
Earnings call transcript
2023 Q2
22 Nov 22
MDT
Earnings call transcript
2023 Q1
23 Aug 22
MDT
Earnings call transcript
2022 Q4
26 May 22
MDT
Earnings call transcript
2022 Q3
22 Feb 22
MDT
Earnings call transcript
2022 Q2
23 Nov 21
MDT
Earnings call transcript
2021 Q2
24 Aug 21
MDT
Earnings call transcript
2021 Q4
27 May 21
MDT
Earnings call transcript
2021 Q3
23 Feb 21
MDT
Earnings call transcript
2021 Q2
24 Nov 20
Latest ownership filings
SC 13G/A
BlackRock Inc.
15 Feb 23
SC 13G/A
VANGUARD GROUP INC
9 Feb 23
SC 13G
Orchestra BioMed Holdings, Inc.
6 Feb 23
4
Jennifer M Kirk
2 Feb 23
4
Orchestra BioMed Holdings, Inc.
1 Feb 23
3
Orchestra BioMed Holdings, Inc.
1 Feb 23
4
Sean Salmon
16 Dec 22
4
Ivan K Fong
13 Dec 22
4
ROBERT JOHN WHITE
9 Dec 22
4
Brett A. Wall
9 Dec 22
Financial summary
| Quarter (USD) | Jan 23 | Oct 22 | Jul 22 | Apr 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Apr 22 | Apr 21 | Apr 20 | Apr 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 4.52 bn | 4.52 bn | 4.52 bn | 4.52 bn | 4.52 bn | 4.52 bn |
| Cash burn (monthly) | 102.33 mm | (no burn) | (no burn) | (no burn) | (no burn) | (no burn) |
| Cash used (since last report) | 215.34 mm | n/a | n/a | n/a | n/a | n/a |
| Cash remaining | 4.31 bn | n/a | n/a | n/a | n/a | n/a |
| Runway (months of cash) | 42.1 | n/a | n/a | n/a | n/a | n/a |
Institutional ownership, Q4 2022
80.6% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 1837 |
| Opened positions | 199 |
| Closed positions | 179 |
| Increased positions | 635 |
| Reduced positions | 842 |
| 13F shares | Current |
|---|---|
| Total value | 82.85 tn |
| Total shares | 1.07 bn |
| Total puts | 5.71 mm |
| Total calls | 9.38 mm |
| Total put/call ratio | 0.6 |
| Largest owners | Shares | Value |
|---|---|---|
| Vanguard | 125.13 mm | $9.72 tn |
| BLK Blackrock | 122.29 mm | $9.50 tn |
| STT State Street | 60.03 mm | $4.71 tn |
| Massachusetts Financial Services | 35.40 mm | $2.75 tn |
| Wellington Management | 29.86 mm | $2.32 tn |
| Capital Research Global Investors | 28.81 mm | $2.24 tn |
| Geode Capital Management | 27.22 mm | $2.12 tn |
| BAC Bank Of America | 23.63 mm | $1.84 tn |
| JPM JPMorgan Chase & Co. | 20.02 mm | $1.56 tn |
| BK Bank Of New York Mellon | 19.59 mm | $1.52 tn |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 Feb 23 | Kirk Jennifer M | Ordinary Shares | Payment of exercise | Dispose F | No | No | 85.77 | 672 | 57.64 k | 10,115 |
| 30 Jan 23 | Medtronic | Common Stock | Buy | Acquire P | Yes | No | 9.281 | 6,835 | 63.44 k | 4,999,423 |
| 13 Dec 22 | Sean Salmon | Ordinary Shares | Sell | Dispose S | No | No | 80.4964 | 16,631 | 1.34 mm | 36,088 |
| 13 Dec 22 | Sean Salmon | Ordinary Shares | Option exercise | Acquire M | No | No | 55.32 | 14,823 | 820.01 k | 52,719 |
| 13 Dec 22 | Sean Salmon | Ordinary Shares | Option exercise | Acquire M | No | No | 55.32 | 1,808 | 100.02 k | 37,896 |
| 13 Dec 22 | Sean Salmon | Stock Option Ordinary Shares | Option exercise | Dispose M | No | No | 55.32 | 14,823 | 820.01 k | 0 |
| 13 Dec 22 | Sean Salmon | Stock Option Ordinary Shares | Option exercise | Dispose M | No | No | 55.32 | 1,808 | 100.02 k | 0 |
| 9 Dec 22 | Ivan K Fong | Ordinary Shares | Payment of exercise | Dispose F | No | No | 78.59 | 5,206 | 409.14 k | 32,830 |
News
Reported Late Thursday March 23, Medtronic Announces Pricing Of $2B Of Senior Notes
24 Mar 23
Check Out What Whales Are Doing With MDT
22 Mar 23
Medtronic To Boost AI Innovation With New Platform Introduction; Strategic Collaboration With Cosmo Pharmaceuticals And Nvidia Delivers The GI Genius AI Access Platform Designed To Accelerate AI Innovation For Healthcare
22 Mar 23
10 High Yield, Cheap Dividend Stocks To Buy Right Now
21 Mar 23
Medtronic And NVIDIA Collaborate To Build AI Platform For Medical Devices
21 Mar 23
Press releases
Medtronic Announces Pricing of $2.0 Billion of Senior Notes
23 Mar 23
Medtronic to boost AI innovation with new platform introduction
22 Mar 23
Medtronic receives CE Mark approval for Affera™ Mapping and Ablation System to treat atrial arrhythmias
15 Mar 23
Airway Management Devices Market to Grow at a Tremendous CAGR of 7.6% with Forecast by 2028 | Exactitude Consultancy
14 Mar 23
Medtronic named one of World's Most Ethical Companies
13 Mar 23